URAC

COVID-19 Declined among Top Five Telehealth Diagnoses Nationally and in Most Regions in September 2022

Retrieved on: 
Lunedì, Dicembre 5, 2022
CMS, Certification, Agency for Healthcare Research and Quality, Centers for Medicare & Medicaid Services, AHRQ, Agency, Government, Diagnosis, Patient, HITRUST, Collection, Kiplinger, Hospital, FAIR, Health, CPT, Medicare Advantage, AICPA, News, Medicaid, COVID-19, Map, The Price, URAC, Medicare Part D, Personal finance, Infection, Database, Telehealth, Medicare, PIP, Pharmaceutical industry, Health insurance

NEW YORK, Dec. 5, 2022 /PRNewswire/ -- COVID-19 declined among the top five telehealth diagnoses nationally and in most US census regions from August to September 2022, according to FAIR Health's Monthly Telehealth Regional Tracker. Nationally and in the Midwest, COVID-19 fell from second to third place in the rankings. In the South, it fell from third to fifth place, and in the West, it fell from third place out of the rankings. Only in the Northeast did COVID-19 maintain its position at second place. The data represent the privately insured population, including Medicare Advantage and excluding Medicare Fee-for-Service and Medicaid.

Key Points: 
  • NEW YORK, Dec. 5, 2022 /PRNewswire/ -- COVID-19 declined among the top five telehealth diagnoses nationally and in most US census regions from August to September 2022, according to FAIR Health's Monthly Telehealth Regional Tracker .
  • In addition to the changes involving COVID-19, acute respiratory diseases and infections rose among the top five telehealth diagnoses nationally and in most regions from August to September 2022.
  • The rankings of the top five telehealth specialties did not change nationally or regionally from August to September 2022.
  • For September 2022, the Telehealth Cost Corner spotlighted the cost of CPT 99441, 5-10-minute telephone medical discussion with physician.

FAIR Health Initiative Demonstrates Appetite for Shared Decision-Making Tools among Patients of Color

Retrieved on: 
Martedì, Novembre 29, 2022
Personal finance, Doctor of Philosophy, Patient, AICPA, CMS, Government, Language isolate, AHRQ, Health, Type 2 diabetes, Organization, HITRUST, PIP, Hospital, Certification, ITI, Caregiver, Kiplinger, Agency, Friends, Database, Centers for Medicare & Medicaid Services, Diabetes, Medicare, FAIR, Agency for Healthcare Research and Quality, Focus, Collection, Medicare Part D, URAC, News, Health insurance

NEW YORK, Nov. 29, 2022 /PRNewswire/ -- An initiative to advance shared decision making among patients of color in New York State revealed an appetite for this type of discussion among patients and providers and the utility of tools that facilitate such discussions. Shared decision making is the exchange among patients, caregivers and healthcare providers, balancing clinical options and patient preferences to make treatment decisions. The initiative, generously funded by the New York Health Foundation (NYHealth) and undertaken in collaboration with FAIR Health Academic Advisory Board member Chima Ndumele, PhD, offered salient insights as to how patients make decisions and challenges they may face when navigating the healthcare system and managing healthcare costs. These and other insights are included in a brief released today by FAIR Health, Advancing Shared Decision Making among Patients of Color: Lessons Learned from FAIR Health's Grant-Funded Initiative.

Key Points: 
  • These and other insights are included in a brief released today by FAIR Health, Advancing Shared Decision Making among Patients of Color: Lessons Learned from FAIR Health's Grant-Funded Initiative .
  • The tools combine clinical and cost information, and reside in a dedicated shared decision-making section of the FAIR Health Consumer (fairhealthconsumer.org) website.
  • FAIR Health promoted the tools through a robust, culturally sensitive dissemination campaign to a variety of stakeholders: providers, patients, community organizations, state and federal departments of health and organizations that serve and advocate for communities of color, among others.
  • Of the initiative, FAIR Health President Robin Gelburd said, "FAIR Health wishes to thank the New York Health Foundation for supporting this groundbreaking initiative.

Amber Specialty Pharmacy Selected to Dispense TZIELD™ (teplizumab), a Monoclonal Antibody Treatment to Delay Onset of Stage 3 Type 1 Diabetes in Patients Ages 8 Years and Older with Stage 2 Type 1 Diabetes

Retrieved on: 
Lunedì, Novembre 21, 2022
Diabetes, Pharmaceutical, Health, ACHC, National Association, T1D, Specialty pharmacy, Autoantibody, Child, Person, Accreditation Commission for Health Care, Pharmacy, URAC, Patient, Hospital

Amber Specialty Pharmacy announces that it will begin dispensing TZIELD (teplizumab), an anti-CD3 monoclonal antibody, to delay Stage 3 Type 1 Diabetes (T1D) in patients ages 8 years and older with Stage 2 T1D.

Key Points: 
  • Amber Specialty Pharmacy announces that it will begin dispensing TZIELD (teplizumab), an anti-CD3 monoclonal antibody, to delay Stage 3 Type 1 Diabetes (T1D) in patients ages 8 years and older with Stage 2 T1D.
  • Living with or caring for a child with T1D requires constant daily management, said Kristin Williams, president of Amber Specialty Pharmacy.
  • Amber Specialty Pharmacy has built an exceptional reputation by providing personalized support and quality clinical care to patients and families.
  • Amber Specialty Pharmacy was named the 2020 Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy.

Optime Care Recognizes Role of Caregivers for Individuals with Rare Disease, Chronic, Complex Conditions

Retrieved on: 
Martedì, Novembre 15, 2022
Family, Consumer, Health, Pharmaceutical, Managed Care, ACHC, Partnership, Accreditation, Caregiver, Disorder, Pharming, Disease, Accreditation Commission for Health Care, URAC, Patient, Residential care, Hospital

Optime Care , a national specialty pharmacy, distribution and patient management organization, maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is pleased to recognize November as National Family Caregivers Month and expresses its appreciation for caregivers across the nation who are providing essential care for rare disease patients and those with chronic, complex conditions.

Key Points: 
  • Optime Care , a national specialty pharmacy, distribution and patient management organization, maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is pleased to recognize November as National Family Caregivers Month and expresses its appreciation for caregivers across the nation who are providing essential care for rare disease patients and those with chronic, complex conditions.
  • Healthcare issues that impact the day-to-day care of patients with rare conditions are extremely complex, often challenging the ability of untrained caregivers largely family members who are tasked with these responsibilities, says Brandon Salke, Pharm.D., general manager and pharmacist-in-charge, Optime Care.
  • With over 53 million family members providing caregiving to a loved one and 20 million becoming new caregivers each year, we honor and support caregivers and their pivotal role not only during November, but also throughout the year.
  • We recognize that these ongoing duties can be overwhelming for even the most dedicated caregivers, says Salke.

Truepill Closes Fundraising Round to Refocus on Core Pharmacy and Accelerated Customer Growth

Retrieved on: 
Venerdì, Novembre 11, 2022
Health, FDA, Pharmacy, Investment, URAC, Entrepreneurship, GLOBE, Solution, GoodRx, SAN, Accreditation, NABP, B2B, API, Growth, Renewable energy

The fundraising round is timed with Truepills strategy to focus on its core pharmacy business.

Key Points: 
  • The fundraising round is timed with Truepills strategy to focus on its core pharmacy business.
  • In his new role, Greenall will align customer retention and growth with expanded operational capabilities including the companys newest, high volume facility based in Cincinnati, Ohio.
  • Truepill powers the future of consumer healthcare by enabling our customers to deliver modern, digital-first pharmacy experiences at scale.
  • With a nationwide network of owned and operated pharmacies and fulfillment centers, Truepill accreditations include URAC accredited mail order pharmacy, URAC accredited specialty pharmacy, NABP, Digital Pharmacy Accreditation and FDA registration.

Soleo Health Awarded National Accreditations in Three Programs From The Joint Commission

Retrieved on: 
Lunedì, Novembre 7, 2022
Surgery, Other Health, Other Science, Radiology, Research, Pharmaceutical, Oncology, Medical Devices, Infectious Diseases, Hospitals, Genetics, Fitness & Nutrition, Clinical Trials, Cardiology, Science, Biotechnology, Practice Management, Insurance, Nursing, Managed Care, Medical Supplies, Health, General Health, FDA, Diabetes, Professional Services, Leadership, Joint Commission, Company, URAC, Practitioner, Compliance, MS, Multimedia, RN, Pharmacy, Safety, ACHC, Distinction, Health, Joint, Organization, Gold Seal Winery, Patient safety, Gold Seal, Patient, Solution, Hospital, Medicine, Accreditation

Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today it has been awarded three accreditations from The Joint Commission , a global driver of quality improvement and patient safety in healthcare.

Key Points: 
  • Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today it has been awarded three accreditations from The Joint Commission , a global driver of quality improvement and patient safety in healthcare.
  • View the full release here: https://www.businesswire.com/news/home/20221107005840/en/
    Soleo Health earned The Joint Commissions Gold Seal of Approval across three programs by demonstrating continuous compliance with the accrediting organizations standards.
  • New accreditations were awarded for both the home infusion therapy and specialty pharmacy programs and a re-accreditation was earned for home care.
  • Frisco, Texas-based Soleo Health is an innovative national provider of complex specialty pharmacy services administered in the home or at alternate sites of care.

CND Life Sciences Partners with Soleo Health to Broaden the Awareness and Availability of CND's Cutaneous Neurodiagnostic Tests

Retrieved on: 
Giovedì, Novembre 3, 2022
Blood pressure, Media, URAC, Digestion, Education, Neurology, Research, NIA, Perspiration, Partnership, Neuromuscular Disorders, Neurodegeneration, Solution, Autonomic neuropathy, Company, Practitioner, LLC, Synucleinopathy, Pharmacy, National, Dementia, Dysautonomia, NINDS, CND, Pure autonomic failure, Diagnosis, Sleep, Patient, Leadership, Lewy body, SBIR, ACHC, Heart rate, Distinction, Rapid eye movement sleep behavior disorder, Family, Physician, REM, Parkinson's disease, Multiple system atrophy, NIH, Movement disorders, Joint Commission, Health, Medicine, MD, Management, Pharmaceutical industry, Public relations, Stroke, PHOENIX, Ageing

PHOENIX and FRISCO, Texas , Nov. 3, 2022 /PRNewswire/ -- CND Life Sciences (http://cndlifesciences.com), an innovative medical diagnostics company pioneering the detection, visualization, and quantification of protein deposition in cutaneous nerve fibers, is pleased to announce its strategic collaboration with Soleo Health®, a leading national provider of complex specialty pharmacy services, to educate neuromuscular specialists and other neurologists on CND's novel Syn-One Test® and its intraepidermal nerve fiber density assay called Small-Fiber Dx™.

Key Points: 
  • "We are in an era of medicine where precision diagnostics have become increasingly crucial to optimize patient care," said Rick Morello, CND Life Sciences' Chief Executive Officer.
  • "We are quite pleased to work with Soleo Health as a key partner to help CND educate neurologists who could benefit most from incorporating Syn-One and other cutaneous neurodiagnostics into their practice."
  • We are grateful that Soleo Health will help CND educate clinicians on the Syn-One Test and how it can be used effectively in patient care."
  • Additionally, Soleo Health operates more than 40 infusion centers throughout the U.S.
    Visit www.soleohealth.com or connect with Soleo Health on LinkedIn , Facebook and Twitter for more information.

In South and West, COVID-19 Declined among Top Five Telehealth Diagnoses in August 2022

Retrieved on: 
Giovedì, Novembre 3, 2022
Government, Centers for Medicare & Medicaid Services, Infection, Compliance, News, COVID-19, CPT, Medicaid, Medicare, FAIR, Agency, Population, Kiplinger, CMS, URAC, Collection, The Price, Health, Certification, Patient, Agency for Healthcare Research and Quality, Center, PIP, Personal finance, Skin, Map, Telehealth, Medicare Advantage, Medicare Part D, Hospital, AHRQ, Database, HITRUST, AICPA, Health insurance

NEW YORK, Nov. 3, 2022 /PRNewswire/ -- In the South and West, COVID-19 declined among the top five telehealth diagnoses in August 2022, according to FAIR Health's Monthly Telehealth Regional Tracker. In those two US census regions, COVID-19 fell from second place in July to third place in August; in the other two regions, Midwest and Northeast, and nationally, it remained in second place. In all regions and nationally, COVID-19 fell by about one to two percent as a share of telehealth claim lines.1 The data represent the privately insured population, including Medicare Advantage and excluding Medicare Fee-for-Service and Medicaid.

Key Points: 
  • NEW YORK, Nov.3, 2022 /PRNewswire/ --In the South and West, COVID-19 declined among the top five telehealth diagnoses in August 2022, according to FAIR Health's Monthly Telehealth Regional Tracker .
  • Nationally, telehealth utilization increased 1.9 percent, from 5.3 percent of medical claim lines in July to 5.4 percent in August.
  • In the South, telehealth utilization increased 4.7 percent and, in the West, it decreased 1.4 percent.
  • In addition to the changes involving COVID-19 in the South and West, there were other changes to the top five telehealth diagnoses in those regions in August 2022.

Navitus Health Solutions Receives URAC Accreditation In Pharmacy Benefit Management

Retrieved on: 
Martedì, Novembre 1, 2022
Health, Practice Management, Health Technology, Managed Care, General Health, Pharmaceutical, Biotechnology, Achievement, CEO, Patient safety, Pharmacy, PBM, Health, URAC, SSM Health, News, Organization, Prescription, Pharmacy benefit management, Risk management, Compliance, Navitus Bay wind farm, Philosophy, Accreditation, Costco, Health insurance

Navitus Health Solutions, an industry-disrupting pharmacy benefit manager (PBM) thats committed to bringing humanity to pharmacy benefits management through greater transparency and affordability, announced today that it has again been granted full URAC accreditation for Pharmacy Benefit Management.

Key Points: 
  • Navitus Health Solutions, an industry-disrupting pharmacy benefit manager (PBM) thats committed to bringing humanity to pharmacy benefits management through greater transparency and affordability, announced today that it has again been granted full URAC accreditation for Pharmacy Benefit Management.
  • We are very proud to have received our accreditation extension for the fifteenth year, said David Fields, President and CEO of Navitus Health Solutions.
  • We applaud Navitus Health Solutions on achieving URAC accreditation.
  • Navitus Health Solutions, owned by SSM Health and Costco Wholesale Corporation, is a disruptive industry alternative to traditional pharmacy benefit manager (PBM) models.

Soleo Health’s Los Angeles Pharmacy Earns Three Accreditations From URAC

Retrieved on: 
Lunedì, Ottobre 24, 2022
Clinical Trials, Insurance, Cardiology, Biotechnology, Other Science, Health, Research, Professional Services, Science, Software, Nursing, Medical Supplies, Other Health, FDA, Practice Management, Diabetes, Radiology, Managed Care, Pharmaceutical, General Health, Technology, Oncology, Medical Devices, Infectious Diseases, Hospitals, Risk management, LinkedIn, Accreditation, Joint Commission, Pharmacy, Organization, Health, Patient, Twitter, Multimedia, Facebook, Distinction, Practitioner, URAC, Company, ACHC, Patient safety, Solution, Compliance, Hospital, Medicine, Clinical Trials, Insurance, Cardiology, Biotechnology, Other Science, Health, Research, Professional Services, Science, Software, Nursing, Medical Supplies, Other Health, FDA, Practice Management, Diabetes, Radiology, Managed Care, Pharmaceutical, General Health, Technology, Oncology, Medical Devices, Infectious Diseases, Hospitals

Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today its Los Angeles pharmacy location earned three accreditations from URAC .

Key Points: 
  • Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today its Los Angeles pharmacy location earned three accreditations from URAC .
  • These three latest accreditations for Soleo Health Los Angeles come on the heels of the Company's other pharmacy locations in Chicago, Philadelphia, Phoenix and Columbus also earning URAC Specialty Pharmacy reaccreditation in April 2022.
  • "We applaud Soleo Health Los Angeles on achieving three URAC accreditations.
  • "The Soleo Health Los Angeles URAC accreditations validate the levels of high-quality care and service we bring to patients throughout California.